These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22873688)

  • 1. Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist.
    Yelovitch S; Barr HM; Camden J; Weisman GA; Shai E; Varon D; Fischer B
    J Med Chem; 2012 Sep; 55(17):7623-35. PubMed ID: 22873688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel insulin secretagogue based on a dinucleoside polyphosphate scaffold.
    Eliahu S; Barr HM; Camden J; Weisman GA; Fischer B
    J Med Chem; 2010 Mar; 53(6):2472-81. PubMed ID: 20175517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying reduced P2Y(1) -receptor-mediated relaxation in superior mesenteric arteries from long-term streptozotocin-induced diabetic rats.
    Ishida K; Matsumoto T; Taguchi K; Kamata K; Kobayashi T
    Acta Physiol (Oxf); 2013 Jan; 207(1):130-41. PubMed ID: 22759594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.
    Yelovitch S; Camden J; Weisman GA; Fischer B
    J Med Chem; 2012 Jan; 55(1):437-48. PubMed ID: 22107038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes.
    Yoshida S; Tanaka H; Oshima H; Yamazaki T; Yonetoku Y; Ohishi T; Matsui T; Shibasaki M
    Biochem Biophys Res Commun; 2010 Oct; 400(4):745-51. PubMed ID: 20816753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiabetic activity of benzopyrone analogues in nicotinamide-streptozotocin induced type 2 diabetes in rats.
    Nayak Y; Hillemane V; Daroji VK; Jayashree BS; Unnikrishnan MK
    ScientificWorldJournal; 2014; 2014():854267. PubMed ID: 25548795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPL207280, a Novel G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1-Specific Agonist, Shows a Favorable Safety Profile and Exerts Antidiabetic Effects in Type 2 Diabetic Animals.
    Bazydlo-Guzenda K; Buda P; Matloka M; Mach M; Stelmach F; Dzida R; Smuga D; Hucz-Kalitowska J; Teska-Kaminska M; Vialichka V; Dubiel K; Kaminska B; Wieczorek M; Pieczykolan J
    Mol Pharmacol; 2021 Oct; 100(4):335-347. PubMed ID: 34349026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Podophyllotoxin Derivatives as Partial PPARγ Agonists and their Effects on Insulin Resistance and Type 2 Diabetes.
    Zhang X; Liu H; Sun B; Sun Y; Zhong W; Liu Y; Chen S; Ling H; Zhou L; Jing X; Qin Y; Xiao T; Sun T; Zhou H; Yang C
    Sci Rep; 2016 Nov; 6():37323. PubMed ID: 27853282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of Action.
    Azran S; Danino O; Förster D; Kenigsberg S; Reiser G; Dixit M; Singh V; Major DT; Fischer B
    J Med Chem; 2015 Nov; 58(21):8427-43. PubMed ID: 26447940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice.
    Yoshida S; Ohishi T; Matsui T; Tanaka H; Oshima H; Yonetoku Y; Shibasaki M
    Biochem Biophys Res Commun; 2010 Nov; 402(2):280-5. PubMed ID: 20937249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of determinants required for agonistic and inverse agonistic ligand properties at the ADP receptor P2Y12.
    Schmidt P; Ritscher L; Dong EN; Hermsdorf T; Cöster M; Wittkopf D; Meiler J; Schöneberg T
    Mol Pharmacol; 2013 Jan; 83(1):256-66. PubMed ID: 23093496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-prenylated flavonoid, an antidiabetes constituent in Melicope lunu-ankenda.
    George S; Ajikumaran Nair S; Johnson AJ; Venkataraman R; Baby S
    J Ethnopharmacol; 2015 Jun; 168():158-63. PubMed ID: 25858510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly efficient biocompatible neuroprotectants with dual activity as antioxidants and P2Y receptor agonists.
    Azran S; Förster D; Danino O; Nadel Y; Reiser G; Fischer B
    J Med Chem; 2013 Jun; 56(12):4938-52. PubMed ID: 23751098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural product vindoline stimulates insulin secretion and efficiently ameliorates glucose homeostasis in diabetic murine models.
    Yao XG; Chen F; Li P; Quan L; Chen J; Yu L; Ding H; Li C; Chen L; Gao Z; Wan P; Hu L; Jiang H; Shen X
    J Ethnopharmacol; 2013 Oct; 150(1):285-97. PubMed ID: 24012527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine 5'-O-(1-boranotriphosphate) derivatives as novel P2Y(1) receptor agonists.
    Nahum V; Zündorf G; Lévesque SA; Beaudoin AR; Reiser G; Fischer B
    J Med Chem; 2002 Nov; 45(24):5384-96. PubMed ID: 12431066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemic effect of deoxynojirimycin-polysaccharide on high fat diet and streptozotocin-induced diabetic mice via regulation of hepatic glucose metabolism.
    Li YG; Ji DF; Zhong S; Lin TB; Lv ZQ
    Chem Biol Interact; 2015 Jan; 225():70-9. PubMed ID: 25446853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulinotropic action of 2, 4-dinitroanilino-benzoic acid through the attenuation of pancreatic beta-cell lesions in diabetic rats.
    Jahan H; Choudhary MI; Manzoor M; Khan KM; Perveen S; Atta-Ur-Rahman
    Chem Biol Interact; 2017 Aug; 273():237-244. PubMed ID: 28625491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats.
    Arya A; Looi CY; Cheah SC; Mustafa MR; Mohd MA
    J Ethnopharmacol; 2012 Oct; 144(1):22-32. PubMed ID: 22954496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats.
    Nain P; Saini V; Sharma S; Nain J
    J Ethnopharmacol; 2012 Jun; 142(1):65-71. PubMed ID: 22855943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats.
    Chen F; Xiong H; Wang J; Ding X; Shu G; Mei Z
    J Ethnopharmacol; 2013 Oct; 149(3):729-36. PubMed ID: 23933499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.